Cibus Overview
- Year Founded
-
2001
- Status
-
Public
- Employees
-
185
- Stock Symbol
-
CBUS
- Investments
-
2
- Share Price
-
$18.50
- (As of Friday Closing)
Cibus General Information
Description
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
Contact Information
Corporate Office
- 6455 Nancy Ridge Drive
- San Diego, CA 92121
- United States
Cibus Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $18.50 | $18.37 | $8.90 - $38.85 | $457M | 24.7M | 67.2K | -$25.38 |
Cibus Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 508,167 | 454,358 | 13,843 | 86,064 |
| Revenue | 2,320 | 1,817 | 157 | 25,987 |
| EBITDA | (326,726) | (314,585) | (15,270) | (25,447) |
| Net Income | (285,668) | (267,627) | (16,891) | (29,199) |
| Total Assets | 533,034 | 544,411 | 22,421 | 37,194 |
| Total Debt | 22,872 | 24,621 | 13,911 | 17,876 |
Cibus Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cibus Comparisons
Industry
Financing
Details
000000
00000
Cibus Competitors (10)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AgBiome | Venture Capital-Backed | Durham, NC | 000 | 00000 | 00000000000 | 00000 |
| Inari | Venture Capital-Backed | Cambridge, MA | 000 | 00000 | 00000000000 | 00000 |
| Caribou Biosciences | Formerly VC-backed | Berkeley, CA | 000 | 00000 | 00000000 | 00000 |
| ToolGen | Corporation | Seoul, South Korea | 00 | 0000 | 0000000000 0 | 0000 |
| BioConsortia | Venture Capital-Backed | Davis, CA | 00 | 0000 | 00000000000 | 0000 |
Cibus Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cibus Patents
Cibus Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022345694-A1 | Transforming cannabaceae cells | Pending | 17-Sep-2021 | ||
| CA-3232065-A1 | Transforming cannabaceae cells | Pending | 17-Sep-2021 | 00000000000 | |
| CA-3225278-A1 | Transcription activator-like effectors fused to inteins | Pending | 07-Jul-2021 | 0000000000 | |
| AU-2022308733-A9 | Transcription activator-like effectors fused to inteins | Pending | 07-Jul-2021 | 0000000000 | |
| AU-2022308733-A1 | Transcription activator-like effectors fused to inteins | Pending | 07-Jul-2021 | C12N15/102 |
Cibus Executive Team (19)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Wade King MD | Chief Financial Officer | ||
| Peter Beetham Ph.D | Co-Founder, Chief Operating Officer, President & Board Member | ||
| Jason Stokes | Chief Legal Officer, General Counsel and Corporate Secretary | ||
| Greg Gocal Ph.D | Co-Founder, Chief Scientific Officer & Executive Vice President. | ||
| Tony Moran | Senior Vice President, International Development |
Cibus Board Members (12)
| Name | Representing | Role | Since |
|---|---|---|---|
| Gerhard Prante Ph.D | Cibus | Vice Chairman | 000 0000 |
| Jean-Pierre Lehmann | Self | Board Member | 000 0000 |
| Keith Walker Ph.D | Self | Board Member | 000 0000 |
| Mark Finn | Self | Board Member | 000 0000 |
| Peter Beetham Ph.D | Cibus | Co-Founder, Chief Operating Officer, President & Board Member | 000 0000 |
Cibus Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Cibus Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Cibus Investments & Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| BeeHero | 28-May-2020 | 0000 00000 | 000 | Business/Productivity Software | |
| Nucelis | 06-Jan-2014 | Merger/Acquisition | Biotechnology | 00000 000 |
Cibus Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Nucelis | Biotechnology | San Diego, CA | 0000 |
Cibus ESG
Risk Overview
Risk Rating
Updated April, 01, 2021
34.88 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.00
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 14,042
Rank
Percentile
Software & Services
Industry
00 of 947
Rank
Percentile
IT Consulting
Subindustry
00 of 427
Rank
Percentile
Cibus FAQs
-
When was Cibus founded?
Cibus was founded in 2001.
-
Who is the founder of Cibus?
Peter Beetham Ph.D, Greg Gocal Ph.D, and Rory Riggs are the founders of Cibus.
-
Who is the CEO of Cibus?
Rory Riggs is the CEO of Cibus.
-
Where is Cibus headquartered?
Cibus is headquartered in San Diego, CA.
-
What is the size of Cibus?
Cibus has 185 total employees.
-
What industry is Cibus in?
Cibus’s primary industry is Biotechnology.
-
Is Cibus a private or public company?
Cibus is a Public company.
-
What is Cibus’s stock symbol?
The ticker symbol for Cibus is CBUS.
-
What is the current stock price of Cibus?
As of 17-May-2024 the stock price of Cibus is $18.50.
-
What is the current market cap of Cibus?
The current market capitalization of Cibus is $457M.
-
What is Cibus’s current revenue?
The trailing twelve month revenue for Cibus is $2.32M.
-
Who are Cibus’s competitors?
AgBiome, Inari, Caribou Biosciences, ToolGen, and BioConsortia are some of the 10 competitors of Cibus.
-
What is Cibus’s annual earnings per share (EPS)?
Cibus’s EPS for 12 months was -$25.38.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
